RESEARCH-USE BIOSIMILAR ANTIBODY
Efalizumab
Monoclonal antibody · IgG1
Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research.
TARGETCD11a
YMonoclonal antibody
CATALOGSC-BS-599
CATALOG NUMBERSC-BS-599
MOLECULAR WEIGHTApprox. 146.238 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research.
Efalizumab is a recombinant research-use antibody directed against CD11a.